Riparian Pharmaceuticals inks license and research agreement with Pfizer for cardiovascular programs
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
To equip them with the latest knowledge and skills to handle patients coming to them in a better way
This transformation will enable GE HealthCare to build a strong foundation for business growth
Deal includes DTx-1252, a potential therapy for the neuromuscular disorder Charcot-Marie-Tooth disease type 1A (CMT1A), and two additional preclinical programs for other neuroscience indications
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
First of its kind screening for Glaucoma at grass root level over 10k screened already
The newly launched Genomic Health Insights (GHI) program to make sequencing accessible to all
The two-part production system is proven to yield high-quality proteins from GS-CHO cell lines, a prevalent mammalian host cell for protein production
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
The collaboration between CARER and Wholeleaf aims to offer an integrated approach to cancer patients, combining services and products to optimize their well-being
Subscribe To Our Newsletter & Stay Updated